Addition of Bevacizumab to Chemotherapy for Treatment of Solid Tumors: Similar Results but Different Conclusions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Addition of Bevacizumab to Chemotherapy for Treatment of Solid Tumors: Similar Results but Different Conclusions

Published:2011-01-20 Issue:3 Volume:29 Page:254-256
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ocaña Alberto¹,Amir Eitan¹,Vera Francisco²,Eisenhauer Elizabeth A.³,Tannock Ian F.¹

Affiliation:

1. Princess Margaret Hospital and University of Toronto, Toronto, Canada

2. Centro Universitario Contra el Cáncer, Hospital Universitario Universidad Autónoma de Nuevo León,Monterrey, México

3. National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.32.0275

Reference18 articles.

1. Endpoints for Assessing Drug Activity in Clinical Trials

2. Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer

3. What Constitutes Reasonable Evidence of Efficacy and Effectiveness to Guide Oncology Treatment Decisions?

4. Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration;Therapeutic Innovation & Regulatory Science;2021-03-08

2. Methoden klinischer Prüfung in der Onkologie;Springer Reference Medizin;2021

3. Gastrointestinal Injury Related to Antiangiogenesis Cancer Therapy;Clinical Colorectal Cancer;2020-09

4. Pharmacogenomics, Pharmacokinetics and Circulating Proteins As Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A Review;Journal of Personalized Medicine;2020-08-04

5. Bevacizumab Moonshots: An Important Outcome From the Latest Ovarian Cancer Mission;Journal of Clinical Oncology;2020-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3